Company / R&D per Share
Ginkgo Bioworks Holdings, Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.48
FY2025
5-year range
$0.31 / $8.48
FY2021-FY2025
Trend
-47.1%
vs FY2024
Sector context
#42 of 207
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s r&d per share of $4.48 is higher than 80% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 7 years, ranging from $0.08 in FY2019 to $8.48 in FY2024.
Based on SEC 10-K filings.
4.48 in FY2025 with a 5-year CAGR of +104.5%. Top quartile in the Health Care sector.
Improved from $0.31 to $4.48 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +90.0%
- 5-Year CAGR
- +104.5%
- 10-Year CAGR
- -
Sector benchmark
-63.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 47.1% year-over-year.
- Ranks #42 out of 207 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.48 | -47.1% |
| FY2024 | $8.48 | +2661.8% |
| FY2023 | $0.31 | -53.0% |
| FY2022 | $0.65 | -26.8% |
| FY2021 | $0.89 | +611.9% |
| FY2020 | $0.13 | +49.5% |
| FY2019 | $0.08 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026